Whitepaper: ARBURG host computer system Read the free white paper to find out how the ARBURG host computer system (ALS) automatically recognises and compensates for production faults More information Draw inspiration from our selection of components To components Benefit from our expertise and lower the costs for your injection moulding production by optimising your energy requirement To the Action Plan: Energy arburgXworld The arburgXworld customer portal gives you access to a wide range of digital apps and features that make your daily work easier To customer portal New: today 87 Read selected articles here and find out more about the highlights from our customer magazine today Read now 02/21/2023 After a year-long planning and development phase the "Faberlab powered by Arburg" Additive Center will be opened on March 2 service provider for industrial additive manufacturing The backdrop to the factory opening: in the future the two companies will collaborate at Faberlab’s Origgio location in Greater Milan The aim is to demonstrate the potentials of industrial additive manufacturing to prospective and existing customers of 3D printing technology on real machines a high-temperature freeformer 300-3X and an innovatiQ TiQ 5 printer with a large build chamber for processing high-performance thermoplastics will be put into operation at Faberlab Customers are set to benefit from the combined knowledge of Faberlab and Arburg The partners will collaborate closely to provide advice on technology and all possible services associated with industrial additive manufacturing manager for additive manufacturing in Italy is the point of contact at Arburg for customers of this technology This pilot project is based on the same blueprint as the Arburg Prototyping Center (APC) which the company operates at its headquarters in Lossburg as well as at its branches in the USA and China customers will be able to have benchmark components manufactured and materials qualified in Italy as well A sales associate from Arburg s.r.l will be the specific point of contact for this customer segment and will also be responsible for contact with Faberlab By strategically expanding its AM expertise in this way Arburg can now specifically meet local expectations and cater to the needs of the Italian market as a whole The on-site team is able to support Freeformer and TiQ customers even faster and in a more specific and extremely practical way has developed high-caliber expertise and knowledge in recent years through its work for the mechanical engineering automotive and plant engineering industries It now brings this know-how to the collaboration Managing Director of ARBURGadditive GmbH + Co KG Manager Additive Manufacturing from Lossburg are also expected to attend the opening of the "digital laboratory" in Origgio They will both be available for technical discussions on the opening day Faberlab and Arburg complement one another perfectly which is why the "Faberlab powered by Arburg" Additive Center is also offering services such as rapid prototyping all-round support along the entire value chain "We support companies and research institutions by developing functional prototypes using different technologies in particular ARBURG Plastic Freeforming APF and innovatiQ’s FDM technology" says Raffaele Abbruzzetti describing the portfolio functional prototypes and small series can be additively manufactured in Origgio from a wide variety of original materials This allows prospective customers of manufacturing systems to determine in advance whether ARBURG Plastic Freeforming or the FDM technology is actually suitable for the desired part material and application before they commit to a purchase To help them become more familiar with the technology existing and prospective customers are also given the opportunity to participate in technology training courses and work with the machine themselves on site The Additive Center is also equipped with laser cutting machines formlabs and cutting edge digital manufacturing technologies that allow the object being manufactured to have a customised additive design Additive printing without compromise is the claim of the "Faberlab powered by Arburg" Additive Center in Origgio Without compromise means that not only standard additive components but complex functional components as well can be produced as hard/soft combinations or with support material material combinations and colours at the highest level of quality and stability are available for industrial scale production Two of many examples are 3D printing using ABS for impact-resistant components with a high quality surface finish and the additive processing of SEBS a highly elastic and soft TPE with good colourability and malleability every requirement for industrial additive manufacturing can now be met Press material The fine and pharmaceutical chemicals firm it was acquired by the British firm BTP in the 1990s and linked up with other BTP acquisitions in the U.S Clariant acquired BTP in 2000 and created a pharmaceutical chemicals business Clariant was disillusioned with the field and sold the business to the venture capital firm TowerBrook Capital Partners an active pharmaceutical ingredient (API) manufacturer that has its roots in the community of small family-owned drug chemical firms clustered around Milan The story of Euticals’ acquisition of Archimica encapsulates several trends in the API sector: serial ownership changes the entry of venture capital into the market ACS’s Basic Package keeps you connected with C&EN and ACS $80 Regular Members & Society Affiliates ACS’s Standard Package lets you stay up to date with C&EN ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer In Archimica’s latest change, Italy takes on more significance. In February, Archimica was acquired by Euticals the push to grow the API business geographically and the broadening of service offerings by companies hoping to establish “one-stop shops” for pharmaceutical clients It also features a high level of risk taking as a regional Italian firm attempts to assimilate a diverse global operation all at once “I think the industry is changing,” says Maurizio Silvestri “I think it is trying to simplify.” By this he means that customers in the drug industry are looking to manage fewer relationships Although amassing a comprehensive service offering is hardly a unique tack in the sector Silvestri sees it as a near-revolutionary move in Italy and an opportunity to build a major player in the traditional home of the small API shop A former vice president for international technical operations at Bristol-Myers Squibb Silvestri was hired as Euticals’ chief operating officer in 2002 by the Carinelli family Part of his job was to integrate three acquisitions the firm had made in Italy: ProBioSint in Varese and Diaspa in Pavia—the last of which was soon divested The moves expanded the company’s API portfolio but Euticals had its eye on global expansion The financial support to do it came in 2008 when the Carinelli family sold 85% of the company to Mandarin Capital Partners a venture capital firm based in China and Italy moved forward on the acquisition of Polichimica The company also acquired a 30% interest in Tianma Tanji a peptides and dosage-form drug producer near Shanghai a specialist in immunosuppressants and muscle relaxants and products like neuromuscular blockers—high-potency drugs,” Silvestri says so the integration has been quick and efficient From the point of view of our product portfolio and technology but we were really worsening our image in terms of being an Italian company presented an ideal opportunity to change that and Archimica brings with it specialized expertise a tetracycline antibiotic that requires advanced hydrogenation Archimica’s site in Germany makes the reagent T3P using a high-yield the company manufactures sterile products; in the U.K. it specializes in difficult reactions involving dinickel sulfate controlled substances are the specialization Archimica facilities also provide capacity “And Euticals is running out of capacity,” Silvestri says “There is still a lot of idle capacity in France.” Euticals has no plan to close down any of Archimica’s operations Euticals’ product mix will shift from 70% APIs to 65% with the acquisition of Archimica whereas contract and custom synthesis will increase from 5% to 10% and the rest of the production is drug intermediates and other fine chemicals compared with about $172 million for Archimica Silvestri says he is looking ahead to yet another acquisition one targeting dosage-form manufacturing in the U.S The company has its eye on opportunities in Asia and Latin America has stated the objective of an initial public offering for the firm president of consulting firm Chemical & Pharmaceutical Solutions is a bit taken aback by Euticals’ global push it will be a bold move on Euticals’ part that takes them from an insignificant player to a real global player,” he says Bruno only sees a “global mess” spurred by an acquisition spree “Euticals was basic in a really niche market,” he explains ‘Expand in the market because we are a venture capital firm and we believe the only way you can grow is through acquisition.’ They have taken on a whole bunch of little pieces Bruno’s misgivings in regard to the Archimica acquisition in particular are based partly on the size of the companies involved “When I looked at Archimica’s product line and then at Euticals’ it was like the proverbial Goliath getting eaten up by David I didn’t think Euticals was big enough to do it.” He adds that Archimica has experienced several ups and downs which will not make Euticals’ road forward any easier Silvestri counters that Archimica is in a better position to succeed under Euticals than with its previous owners “They were not coming from the pharma industry,” he says nor was BTP.” He plans to draw on his experience with Bristol-Myers and notes that many managers at Euticals have international experience as well “Clearly this is a big challenge,” Silvestri says will be to instill a pharma industry focus across the company injecting a current Good Manufacturing Practices ethic even into non-cGMP product areas “We may fail; this is clearly a possibility,” Silvestri acknowledges “But we have a lot of ideas about how to develop Archimica within Euticals Sign up for C&EN's must-read weekly newsletter This article has been sent to the following recipient: Copyright © 2025 American Chemical Society Vito Mollica moved with his family to Origgio From an early age he showed a strong interest in cuisine inspired by the Lucanian specialties prepared by his mother This passion led him to attend the hotel school of the Lecco valleys His career took off in 1996 when he joined the Four Seasons Group where he was able to create a restaurant with its own identity and win significant accolades Mollica returned to Italy to head up Il Palagio at the Four Seasons Hotel in Florence the restaurant was awarded a Michelin star in 2011 he developed a philosophy based on the quality of ingredients and the promotion of local producers advocating the importance of "knowing the man behind the product" opening Chic Nonna inside Palazzo Portinari Salviati reflecting greater control and personal vision in the management of the entire complex. A year later he received his first star at the presentation of the Michelin Guide 2023 His approach to the art of cooking is characterized by balance His dedication and commitment to preserving the country's gastronomic tradition by supporting small producers make him a prominent contemporary figure Do you want to discover the latest news and recipes of the most renowned chefs and restaurants in the world La nostra società utilizza inoltre cookie funzionali per registrare informazioni sulle scelte dell’utente e per consentire una personalizzazione del Sito; ad esempio Questi cookie possono essere installati dalla nostra società o da Terze parti In caso di disabilitazione di questi cookie la qualità e l’esperienza di navigazione potrebbe non essere soddisfacente Questi cookie sono installati da social media per consentire la condivisione dei contenuti del presente Sito Essi sono in grado di monitorare la navigazione compiuta anche in altri siti e creano un profilo dell’utente sulla base dei suoi interessi Ciò potrebbe avere un impatto sul contenuto e messaggi visualizzati sugli altri siti visitati non sarà possibile utilizzare o visualizzare questi strumenti di condivisione per l’installazione e l’uso di tali cookie occorre il consenso dell’utente Per maggiori informazioni consulta la pagna cookies policy this little green bike’s low and slender body adds stability at high-speeds and a tiny handcrafted tank keep weight to a minimum all images © OMT garage / deus milano OMT garage’s brotherly owners felt they had to honor the moped as it was the first form of motorcycle they owned at 14 years old. the bike itself is a 1982 piaggio ‘ciao PX’ or simply ‘ciao’ to those more familiar with it the garage transforms this little racer into the ‘ciao’s’ super-quick cousin.  before: original 1967 piaggio ‘ciao’ the brothers completely modified the tiny two-stroke engine with the front brake now removed from the original ‘ciao’ only the rear brake stops the rider after crossing the finish line it’s activated with the left-hand lever while the lever on the right-hand-side manages the moped’s throttle AXOR presents three bathroom concepts that are not merely places of function but destinations in themselves — sanctuaries of style The global management functions of Archimica will now be located at Archimica's Origgio This organizational change is a part of Archimica's continuous improvement initiative Archimica has named Antonio Benedetti as its new CFO Antonio Benedetti joined Archimica in February Antonio brings years of international financial experience including increasingly more responsible roles in Accounting has joined the Archimica New Business Development Marketing team in the U.S Schwindeman will take over responsibility for several major global innovative pharma firms at the East Coast This is another step in the execution of Archimica's strategic focus on organic growth by significantly investing into the development of new products close customer relationships and innovative technologies Are you ready to elevate your pharmaceutical operations Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals and strategic direction in an exclusive CHEManager International interview.